Algernon Pharmaceuticals Inc. C.AGN

Alternate Symbol(s): AGNPF

Algernon Pharmaceuticals Inc. is a clinical-stage drug development company. The Company is focused on developing repurposed therapeutic drugs in the areas of non-alcoholic steatohepatitis (NASH), a type of liver disease, chronic kidney disease (CKD), inflammatory bowel disease (IBD), idiopathic pulmonary fibrosis (IPF) and chronic cough as well as advancing a stroke program using N, N-Dimethyltryptamine (DMT). The Company operates through two segments, which includes the development of repurposed therapeutic drugs in Canada and the facilitation of the Company’s lead drug candidates into off-label phase II clinical trials (humans) in Australia. The Company's pipeline includes NP-251 (Repirinast) and AP-188 (DMT). The Company, through its subsidiary, Algernon NeuroScience Inc., is developing AP-188 (DMT) as a potential treatment for stroke and traumatic brain injury (TBI) recovery. Its NP-251 is being developed as a potential treatment for kidney inflammation and fibrosis.

CSE:AGN - Post by User

Algernon Pharmaceuticals Inc. > Get out!

<< Previous

Bullboard Posts

Next >>

Comment by GObabyGO1on Mar 05, 2021 5:30pm

161 Views

Post# 32734286

RE:RE:RE:Get out!

I followed this stock for a long time and have seen the good and the bad. There is so much bad going on here and the sad part is you don't see it. It's your money...just trying to warn any new investors to really do your DD because this stock is like a black hole. Your just paying the CEO's salary...have fun with that.

<< Previous

Bullboard Posts

Next >>

Who, why, and what of the great "Crypto Surge"